ipratropium bromide and albuterol sulfate solution
cardinal health 107, llc - ipratropium bromide (unii: j697uz2a9j) (ipratropium - unii:gr88g0i6ul), albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - ipratropium bromide anhydrous 0.5 mg in 3 ml - ipratropium bromide and albuterol sulfate inhalation solution is indicated for the treatment of bronchospasm associated with copd in patients requiring more than one bronchodilator. ipratropium bromide and albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components, or to atropine and its derivatives.
ipratropium bromide and albuterol sulfate inhalant
medical supply distribution, llc. - ipratropium bromide (unii: j697uz2a9j) (ipratropium - unii:gr88g0i6ul), albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - ipratropium bromide anhydrous 0.5 mg in 3 ml - indications and usage ipratropium bromide and albuterol sulfate inhalation solution is indicated for the treatment of bronchospasm associated with copd in patients requiring more than one bronchodilator. contraindications ipratropium bromide and albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components, or to atropine and its derivatives. read this patient information completely every time your prescription is filled as information may have changed. keep these instructions with your medication as you may want to read them again. ipratropium bromide and albuterol sulfate inhalation solution should only be used under the direction of a physician. your physician and pharmacist have more information about ipratropium bromide and albuterol sulfate inhalation solution and the condition for which it has been prescribed. contact them if you have additional questions. store ipratropium bromide and albuterol sulfate inhalation solution between
ipratropium bromide and albuterol sulfate solution
golden state medical supply, inc. - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e), ipratropium bromide (unii: j697uz2a9j) (ipratropium - unii:gr88g0i6ul) - ipratropium bromide anhydrous 0.5 mg in 3 ml - ipratropium bromide and albuterol sulfate inhalation solution is indicated for the treatment of bronchospasm associated with copd in patients requiring more than one bronchodilator. ipratropium bromide and albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components, or to atropine and its derivatives.
ipramol steri-neb
norton healthcare limited t/a ivax pharmaceuticals uk - ipratropium bromide monohydrate ; salbutamol sulfate - nebuliser solution - 0.5/2.5 mg/mg - salbutamol and ipratropium bromide
ipramol steri-neb 0.5 mg/2.5 mg per 2.5 ml nebuliser solution
teva b.v. - ipratropium bromide; salbutamol sulfate - nebuliser solution - 0.5/2.5 mg/mg - adrenergics in combination with anticholinergics; salbutamol and ipratropium bromide
ipratropium bromide/salbutamol neutec 0.5 mg - 2.5 mg nebul. sol. single-dose cont.
neutec inhaler ireland ltd. - ipratropium bromide monohydrate 0,522 mg - eq. ipratropium bromide 0,5 mg; salbutamol sulfate 3,012 mg - eq. salbutamol 2,5 mg - nebuliser solution - salbutamol and ipratropium bromide
combiprasal 0.5 mg/2.5 mg per 2.5 ml nebuliser solution
pharma stulln gmbh - ipratropium bromide; salbutamol sulfate - nebuliser solution - 0.5 mg/2.5 milligram(s) - adrenergics in combination with anticholinergics; salbutamol and ipratropium bromide
salbutamol sandoz salbutamol 5mg/2.5ml (as sulfate) inhalation ampoules
sandoz pty ltd - salbutamol sulfate -
salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules
actavis uk ltd - salbutamol sulfate; ipratropium bromide - nebuliser liquid - 1mg/1ml ; 200microgram/1ml
ipratropium bromide and albuterol sulfate solution
cipla usa inc. - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e), ipratropium bromide (unii: j697uz2a9j) (ipratropium - unii:gr88g0i6ul) - albuterol 2.5 mg in 3 ml - ipratropium bromide and albuterol sulfate inhalation solution is indicated for the treatment of bronchospasm associated with copd in patients requiring more than one bronchodilator. ipratropium bromide and albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components, or to atropine and its derivatives.